Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 341309Generated: October 25, 2026

Sodium triacetoxyborohydride → (S)-1-(4-((2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one

https://huagongshe.com/reaction/341309

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium triacetoxyborohydrideHCID 5049666—
ReactantBorane;2-methylpyridineHCID 16217944—
Reactant2-Chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehydeHCID 56648582—
Reactant(S)-2-hydroxy-1-(piperazin-1-yl)propan-1-oneHCID 68437343—
ReactantHCID 178419175HCID 178419175—
Product(S)-1-(4-((2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-oneHCID 86623526—

Reaction Steps

Scheme 2 shows the synthesis of intermediate (S)-1-(4-((2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one II from 4-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)morpholino VI. Treatment of VI with isopropylmagnesium chloride Grignard reagent followed by n-butyllithium at −10° C. was followed by addition of dimethylformamide and quenching with aqueous acid gave formylated intermediate 2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde IV (Example 4). Reductive amination of IV was effected by mixing IV with the oxalate salt of (S)-2-hydroxy-1-(piperazin-1-yl)propan-1-one V followed by a reducing agent, such as sodium triacetoxyborohydride (Method A), 2-picoline borane (Method B) or 5-Ethyl-2-methylpyridine borane to give II which was crystallized in toluene/heptane (Example 5) or Me-THF/heptane.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08895729B2
Source datasetuspto-grants-2014_11
ORD IDord-cb5040194e574905a938d2f91e3025c9
Source noteuspto-grants-2014_11